Clinilabs, a specialty contract research organization (CRO), collaborated with AMPS, LLC to create TrialPerfect version 1.0.0, AMPS back-end database system that completes the well-know CalECG product, the AMPS on-screen measurement tool, providing a complete solution for clinical trials.

For the development of this innovative software, Clinilabs provided support to AMPS from clinical and core laboratory perspectives. Clinilabs' collaboration with AMPS to produce TrialPerfect gives it a competitive advantage and assures sponsors of service that is incomparable to other vendors of ECG Core Lab services.

"TrialPerfect enables us to efficiently handle ECG data obtained from single-center studies to large, multi-center clinical trials. This application, along with Clinilabs' proprietary methods, allows us to offer exceptional service at competitively low-cost to pharmaceutical and biotechnology companies that expect only the best," stated Dr Gary Zammit, Clinilabs' President and CEO.

Fabio Badilini, chief scientist at AMPS commented, "We are very pleased with the fruitful cooperation we have developed with Clinilabs for the development of TrialPerfect. Nowadays AMPS has the capability to offer a full key-in-hand package to its customers."

The first installation of TrialPerfect was conducted at Clinilabs. The combination of TrialPerfect and CalECG offer a safe client/server environment for the storage, analysis, interpretation, validation, and review of ECG traces in the context of clinical trials.

Clinilabs is a specialty contract research organization (CRO) that provides a full portfolio of services to pharmaceutical, biotechnology, and medical device companies involved in the development of central nervous system (CNS) and cardiovascular (CV) therapeutics.

AMPS LLC, based in New York, is a leading edge software company providing software solutions used specifically by Clinical Research Organizations and Pharmaceutical corporations in the field of quantitative ECG analysis and blood pressure monitoring.